Household Healthcare Sector

HST Global

Market Cap: US$48.0m

Operates as an integrated health and wellness biotechnology company in the United States.

Mural Oncology

Market Cap: US$47.7m

Operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer.

Adverum Biotechnologies

Market Cap: US$47.4m

A clinical-stage company, develops gene therapy product candidates to treat ocular diseases.

EZZ Life Science Holdings

Market Cap: AU$73.6m

Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.

PepGen

Market Cap: US$47.1m

A clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States.

Quince Therapeutics

Market Cap: US$46.8m

A biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases.

PMV Pharmaceuticals

Market Cap: US$46.8m

A precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer.

Forte Biosciences

Market Cap: US$46.8m

Operates as a clinical-stage biopharmaceutical company in the United States.

Opus Genetics

Market Cap: US$46.4m

A clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of inherited retinal diseases (IRDs).

Reviva Pharmaceuticals Holdings

Market Cap: US$46.3m

A biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases.

Zomedica

Market Cap: US$46.1m

A veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals.

Apiam Animal Health

Market Cap: AU$71.7m

A vertically integrated animal health company, provides veterinary products and services to production and companion animals, and equine in Australia.

Anebulo Pharmaceuticals

Market Cap: US$46.0m

A clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States.

Hyperfine

Market Cap: US$45.9m

A health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products.

Maverick Lifestyle

Market Cap: US$45.4m

Engages in the manufacture, branding, marketing, distribution, and sale of products infused with hemp-derived cannabinoids in the United States.

Cue Biopharma

Market Cap: US$45.3m

A clinical-stage biopharmaceutical company, develops a novel class of injectable therapeutics to selectively engage and modulate targeted, disease relevant T cells in the United States.

Modular Medical

Market Cap: US$45.2m

Operates as a medical device company.

BioNxt Solutions

Market Cap: CA$62.5m

Engages in R&D and manufacturing of thin-film (sublingual) and skin patch (transdermal) drug delivery for neurological and autoimmune diseases, enhancing patient compliance and bioavailability.

Connect Biopharma Holdings

Market Cap: US$45.1m

A clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cell-driven inflammatory diseases.

RenovoRx

Market Cap: US$44.6m

A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.

NRx Pharmaceuticals

Market Cap: US$44.5m

A clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain.

Earth Science Tech

Market Cap: US$44.1m

Focuses on health and wellness industry.

House of Jane

Market Cap: US$44.1m

Provides lifestyle therapy products.

Medical Developments International

Market Cap: AU$68.7m

Manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally.

Mersana Therapeutics

Market Cap: US$44.0m

A clinical-stage biopharmaceutical company, develops antibody-drug conjugates (ADC) for cancer patients with unmet needs.

ANGLE

Market Cap: UK£32.3m

A medical diagnostic company, engages in developing cancer diagnostics products in the United Kingdom, Europe, North America, and internationally.

Xilio Therapeutics

Market Cap: US$43.2m

A clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies.

Microba Life Sciences

Market Cap: AU$67.2m

Provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland.

Rein Therapeutics

Market Cap: US$42.7m

A biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States.

Neurizon Therapeutics

Market Cap: AU$66.5m

A clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases in Switzerland, Australia, the United States, and internationally.

Firefly Neuroscience

Market Cap: US$42.4m

A medical technology and artificial intelligence company, provides neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders.

Vicarious Surgical

Market Cap: US$42.2m

Develops and sells single-port surgical robot in the United States.

Actinogen Medical

Market Cap: AU$65.8m

A biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia.

Nowtransit

Market Cap: US$41.6m

Distributes clinically tested and affordably priced products to battle the onslaught of bacteria and viruses.

ImpediMed

Market Cap: AU$64.8m

A medical technology company, manufactures, and sells bioimpedance spectroscopy (BIS) technology medical devices in the Unites States and Europe.

LianBio

Market Cap: US$41.1m

A biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, opthalmology, and inflammatory diseases in China and other Asian countries.